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using a protein assay kit (Bio-Rad Laboratories, Hercules, California) with bovine serum albumin used as the standard. The supernatants were boiled in sample buffer (35 mM Tris-HCl, pH 6.8, 4% SDS, 9.3% dithiothreitol, 0.01% bromophenol blue, 30% glycerol) at 95°C for 5 min. The samples were stored at -20°C until use.
Immunoblotting
Immunoblotting was performed as previously described [13, 19, 20] . Lysates from macrophages were prepared as previously described. Samples containing 50 µg of cell proteins were separated by SDS-PAGE in a 9% polyacrylamide gel and then electrotransferred to polyvinylidene difluoride membranes. The membrane was blocked in TBS (Tris-buffered saline) containing 5% non-fat dry milk for 2 , and then incubated with primary antibodies [goat anti-mouse D 1 R (1:200), rabbit anti-mouse D 5 R (1:500), rabbit anti-mouse α-actin (1:400) (Santa Cruz, Dallas, TX) and rabbit anti-mouse Akt/ERK/PI3K (1:800), rabbit anti-mouse phosphoAkt/ERK/PI3K (1:600) (Cell Signaling, Boston, MA)] overnight at 4°C. The membranes were then further incubated with IRDye 800 infrared-labeled donkey anti-rabbit/monkey anti-goat secondary antibodies (Li-Cor Biosciences, Lincoln, NE) at room temperature for 1 h. The membranes were then washed three times with phosphate buffered saline (PBS)-Tween-20. The bound complex was detected using the Odyssey Infrared Imaging System (Li-Cor Biosciences). The images were analyzed using the Odyssey Application Software to obtain the integrated intensities.
RT-PCR of D 1 -like receptors
A total of 2-3 μg of total RNA extracted from RAW264.7 cells was used to synthesize cDNA, which served as a template for the amplification of dopamine D 1 -like receptors [12] . For the mouse dopamine D 1 receptor, the forward primer was: 5ˊ-GTA GCC ATT ATG ATC GTCAC-3ˊ and the reverse primer was: 5ˊ-GAT CAC AGA CAG TGT CTT CAG-3ˊ; for the mouse dopamine D 5 receptor, the forward primer was: 5ˊ-CTA CGA GCG CAA GAT GACC-3ˊ and the reverse primer was: 5ˊ-CTC TGA GCA TGC TCA GCTG-3ˊ; for the mouse β-actin, the forward primer was: 5ˊ-CCT CTA TGC CAA CAC AGTGC-3ˊ and the reverse primer was: 5ˊ-GTA CTC CTG CTT GCT GATCC-3ˊ. The amplification was performed with the following conditions: denaturation at 94°C for 30 s, annealing for 30 s at 60°C, and extension for 45 s at 72 0 C for 35 cycles. PCR products were visualized in ethidium bromide-stained 2% agarose gels, and band sizes were compared with a 600 bp DNA ladder (Gibco).
Immunohistochemistry
Cells grown in 6-well plates were fixed for 30 min in PBS containing 4% paraformaldehyde and washed three times with PBS alone. Fixed cells were incubated with anti-dopamine D 1 and D 5 receptor antibody (1:200) at 4°C overnight. After incubation with the primary antibodies, cells were rinsed three times with PBS and incubated for 60 min at 37°C with 10 µg/ml of biotin-conjugated goat anti-rabbit or monkey antigoat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA). The cells were again washed three times with PBS and incubated for 20 min at room temperature with an avidin-biotin peroxidase complex (Elite ABC kit; Vector Laboratories Inc., Burlingame, California) followed by development for 10 min using 3-amino-9-ethylcarbazole and peroxide with a kit from Calbiochem. Images were obtained using a Leica DMLS microscope (Leica Microsystems, Buffalo Grove, IL) [21] . [22] . Human LDL was oxidized using Cu 2 SO 4 (oxidant) in PBS. Oxidation was terminated by adding excess EDTANa 2 . After induction of quiescence, the cells were stimulated with Ox-LDL (Yiyuan Co., Guangzhou City, China) or vehicle (dH 2 O) in the presence or absence of fenoldopam, PD98059 or LY294002 (Sigma-Aldrich, St. Louis, MO) for 48 h. The antagonists and inhibitors were added to the medium 30 min prior to the corresponding agonists. Thereafter, [ 3 H]-thymidine (1 mCi/ml) was added to the growth medium of each well 6 h prior to the measurements. At the end of the incubation period, the medium was removed and the cells were treated with 0.25 ml of 0.05% trypsin/0.53 mM EDTA (Gibco) for 5 min and diluted to 10 ml with a balanced electrolyte solution [12] . The cells were then treated with 10% trichloroacetic acid to precipitate acid-insoluble materials from which the DNA was extracted using 0.1 N NaOH. The DNA was collected on Cellular Physiology and Biochemistry a Whatman GF/B filter and washed twice with 5 ml ice-cold PBS. The filter was then cut and shaken in 3.5 ml scintillation fluid for 24 h before being counted in a liquid scintillation counter (Beckman LS6500, Beckman, MO). Protein concentrations were determined using a BCA protein assay kit (Pierce, Rockford, IL), as previously described [23] . Data are presented as [ 
MTT assay
The number of viable cells in each well was also estimated by the uptake of the tetrazolium salt, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT). MTT is selectively taken up by mitochondria and converted to a dark blue product by living but not by dead cells. After the induction of quiescence in 96-well plastic culture dishes at a density of 1×10 3 cells/well, the cells were incubated with the indicated reagents for 48 h. Subsequently, 20 μl of MTT (2.5 g/L) was added to each well, and the incubation continued for an additional 4 h at 37°C. Thereafter, 150 μl DMSO was added to each well, and absorbance was read at 490 nm on a microplate reader (model 680, Bio-Rad, Hercules, CA).
Statistical analysis
The data are expressed as the mean ± SEM. Comparison within groups was made by repeated measures ANOVA (or paired t-test when only 2 groups were compared), and comparison among groups was made by factorial ANOVA with a Holm-Sidak ad hoc test (or t-test when only 2 groups were compared). A value of P<0.05 was considered significant.
Results

The Ox-LDL-mediated proliferation of RAW264.7 cells is attenuated by the activation of dopamine D 1 -like receptors
First, we assessed whether the D 1 -like receptors, including the D 1 and D 5 receptors, were present in macrophages. It was shown that both the D 1 and D 5 receptors were present in macrophages, as determined by immunohistochemistry, immunoblotting and RT-PCR, using human umbilical vein endothelial cells (HUVEC, ATCC, Manassas, VA) as a negative control [24] and the embryonic thoracic aortic smooth muscle cells from normotensive Berlin-Druckrey IX rats (A10, ATCC, Manassas, VA) as a positive control [12, 13] (Fig. 1A-1C) .
Consistent with other reports [1, 16, 25] , Ox-LDL induced proliferation of RAW264.7 cells in a concentration-dependent manner (10-40 µg/ml), as determined by [ 3 H]-thymidine incorporation ( Fig. 2A) . Although fenoldopam alone had no effect on cell proliferation (Fig.  2B) , it reduced the Ox-LDL-mediated RAW264.7 proliferation in a concentration (10 (Fig. 2E, 2F and 2G). To further confirm this result, we used another human macrophage line (THP-1). The results indicated that fenoldopam inhibited Ox-LDL-induced cell proliferation in the presence of a D 1 R antagonist (SCH23390 or SKF83566), as the inhibitory effect of fenoldopam was blocked (Fig. 2G) .
Role of PI3K/Akt and MAPK/ERK signaling pathways in the inhibitory effect of fenoldopam on Ox-LDL-induced proliferation of RAW264.7 cells
PI3K/Akt and MAPK/ERK are known to be important signaling molecules in cell proliferation, migration and apoptosis [1, 12, 16, 26] . Consistent with previous studies [4, 6, 27, 28] , our results showed that the Ox-LDL-mediated proliferation was via the PI3K/Akt and MAPK/ERK pathways because in the presence of PI3K/Akt or MAPK/ERK inhibitors, PD98059 (10 -7 M) and LY294002 (10 -5 M), respectively, the Ox-LDL (20 µg/ml)-mediated
The expressions of D 1 -like receptors are decreased in peritoneal macrophages obtained from apoE -/-mice The Apolipoprotein E-deficient mouse is an animal model of atherosclerosis with high levels of Ox-LDL [2] . Due to the inhibitory effect of fenoldopam on macrophage proliferation, we investigated whether the dopamine receptor expression is aberrant in apoE -/-mouse cells. We found that both the D 1 and D 5 receptor expression in peritoneal macrophages was lower compared to the control mice (Fig. 4A) . We observed that treatment with Ox-LDL led to the decreased expression of D 1 and D 5 receptors in vitro, suggesting that hyperlipidemia may also play a major role in the inhibition of the receptor expression (Fig. 4B) . 
Discussion
Previous studies have shown that the proliferation of cells, including vascular smooth muscle cells and macrophages, within arterial walls is a major event in the formation of atherosclerotic lesions [4, 6, 12, 24, 29] . In vitro and in vivo studies strongly suggest that macrophages and macrophage-derived foam cells proliferate in atherosclerotic lesions and may be involved in the enhanced progression of atherosclerosis in vivo [6, [30] [31] [32] . Ox-LDL is an important risk factor, and although the mechanisms are complex, it is believed that the stimulatory effect of Ox-LDL on macrophage proliferation plays an important role [1, 6, 24] . Dopamine receptors are expressed in many organs and tissues, and stimulation of the dopamine D 1 -like receptors prevents atherosclerosis via the inhibition of proliferation, migration and oxidation of VSMCs [12] [13] [14] [15] . Dopamine D 1 -like receptors are present in VSMCs, platelets, lymphocytes and natural killer cells [33, 34] . Our current study shows that both D 1 and D 5 receptors are expressed in macrophages. Activation of the D 1 -like receptors reduced the Ox-LDL-induced proliferation in both RAW264.7 and THP-1 cells, indicating that they are involved in the pathogenesis of atherosclerosis as D 1 and D 5 receptor expression in peritoneal macrophages are lower in apoE -/-compared to the C57Bl/6J control mice. The mechanisms of Ox-LDL-induced macrophage proliferation are complex and include processes such as an increase in intracellular calcium, activation of protein kinase C (PKC), and secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) [35] [36] [37] . PI3K/Akt and MAPK/ERK are believed to be involved in downstream signaling [4, 26, 38] . The MAPK signaling pathway includes ERK, JNK and p38 MAPK; the ERK pathway is the most common cell proliferative response-mediated signaling pathway [1, 39] . PI3K/Akt is one of the major signaling pathways in cell proliferation and has been identified as an important factor in cancer [40] . When PI3K is activated, it generates a second messenger in the cell membrane: PIP 3 , which binds to and activates Akt. Akt, also known as protein kinase B (PKB), has a relatively large molecular mass of 60,000 Da and phosphorylates a variety of transcription factors directly and can therefore inhibit apoptosis gene expression and enhance the anti-apoptotic gene expression, thereby promoting cell survival [1, 26] . In the present study, we first confirmed that the Ox-LDL-mediated proliferation was via the PI3K/ Akt and MAPK/ERK pathways. Then, we found that stimulation with fenoldopam, the D 1 -like receptor agonist, decreases the Ox-LDL-induced ERK and Akt phosphorylation, which suggests that the inhibitory effect of D 1 -like receptors on Ox-LDL-induced proliferation of macrophages may be through inhibition of PI3K/Akt and MAPK/ERK signaling pathways. Moreover, we also found that fenoldopam reduced the stimulatory effect of Ox-LDL on the p-ERK. The inhibitory effect of fenoldopam is via the cAMP/PKA pathway because the effect Our own publications and studies by others have shown the physiological functions of the dopamine receptors on vascular diseases, including anti-atherosclerotic activities [12, 14, 15, 41] . Activation of the D 1 -like receptors inhibits VSMC proliferation and migration induced by factors such as insulin, platelet-derived growth factor (PDGF) BB, and insulinlike growth factor-1(IGF-1) [12, 14, 15, 41] . D 2 -like receptors also suppress the insulin-and angiotensin II-induced VSMC proliferation and migration [42] [43] [44] . Moreover, stimulation 
